Literature DB >> 8123557

Characterization of Eubacterium coprostanoligenes sp. nov., a cholesterol-reducing anaerobe.

T A Freier1, D C Beitz, L Li, P A Hartman.   

Abstract

A small, anaerobic, gram-positive coccobacillus that reduces cholesterol to coprostanol was isolated from a hog sewage lagoon. This isolate, strain HLT (T = type strain) does not require cholesterol for growth, but it requires lecithin and has phospholipase activity. Much acid is produced by the fermentation of amygdalin, lactose, and salicin. Arabinose, cellobiose, fructose, glucose, mannose, and melibiose are fermented weakly. Acetic, formic, and succinic acids are produced, as is hydrogen. The isolate does not reduce nitrate, produce indole, or hydrolyze starch and gelatin. Esculin is hydrolyzed. The properties of strain HLT are most similar to those of members of the genus Eubacterium. Because strain HL (= ATCC 51222) has unique morphological and physiological properties, we propose that it should be the type strain of a new species in the genus Eubacterium, Eubacterium coprostanoligenes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8123557     DOI: 10.1099/00207713-44-1-137

Source DB:  PubMed          Journal:  Int J Syst Bacteriol        ISSN: 0020-7713


  28 in total

1.  Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function.

Authors:  Sofia Cussotto; Conall R Strain; Fiona Fouhy; Ronan G Strain; Veronica L Peterson; Gerard Clarke; Catherine Stanton; Timothy G Dinan; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2018-08-28       Impact factor: 4.530

2.  Habitual Diet Pattern Associations with Gut Microbiome Diversity and Composition: Results from a Chinese Adult Cohort.

Authors:  Yuhan Zhang; Hongda Chen; Ming Lu; Jie Cai; Bin Lu; Chenyu Luo; Min Dai
Journal:  Nutrients       Date:  2022-06-25       Impact factor: 6.706

3.  In vivo Trial of Bifidobacterium longum Revealed the Complex Network Correlations Between Gut Microbiota and Health Promotional Effects.

Authors:  You-Tae Kim; Chul-Hong Kim; Joon-Gi Kwon; Jae Hyoung Cho; Young-Sup Shin; Hyeun Bum Kim; Ju-Hoon Lee
Journal:  Front Microbiol       Date:  2022-06-17       Impact factor: 6.064

4.  Study of anoxic and oxic cholesterol metabolism by Sterolibacterium denitrificans.

Authors:  Yin-Ru Chiang; Wael Ismail; Dimitri Heintz; Christine Schaeffer; Alain Van Dorsselaer; Georg Fuchs
Journal:  J Bacteriol       Date:  2007-11-26       Impact factor: 3.490

5.  Bacteroides sp. strain D8, the first cholesterol-reducing bacterium isolated from human feces.

Authors:  Philippe Gérard; Pascale Lepercq; Marion Leclerc; Françoise Gavini; Pierre Raibaud; Catherine Juste
Journal:  Appl Environ Microbiol       Date:  2007-07-06       Impact factor: 4.792

6.  Integrated microbiome-metabolome analysis reveals novel associations between fecal microbiota and hyperglycemia-related changes of plasma metabolome in gestational diabetes mellitus.

Authors:  Lina Dong; Lingna Han; Tao Duan; Shumei Lin; Jianguo Li; Xiaojing Liu
Journal:  RSC Adv       Date:  2020-01-09       Impact factor: 3.361

7.  Microbiota prevents cholesterol loss from the body by regulating host gene expression in mice.

Authors:  Chun-Yan Zhong; Wei-Wei Sun; Yinyan Ma; Hongling Zhu; Pan Yang; Hong Wei; Ben-Hua Zeng; Qian Zhang; Yu Liu; Wen-Xia Li; Yixin Chen; Liqing Yu; Zhi-Yuan Song
Journal:  Sci Rep       Date:  2015-05-27       Impact factor: 4.379

Review 8.  Catabolism and biotechnological applications of cholesterol degrading bacteria.

Authors:  J L García; I Uhía; B Galán
Journal:  Microb Biotechnol       Date:  2012-02-07       Impact factor: 5.813

9.  Human encroachment into wildlife gut microbiomes.

Authors:  Gloria Fackelmann; Mark A F Gillingham; Julian Schmid; Alexander Christoph Heni; Kerstin Wilhelm; Nina Schwensow; Simone Sommer
Journal:  Commun Biol       Date:  2021-06-25

10.  The Neanderthal meal: a new perspective using faecal biomarkers.

Authors:  Ainara Sistiaga; Carolina Mallol; Bertila Galván; Roger Everett Summons
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.